Clinical Trials
2 trialsNCT01535157 2020-08-27
Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
South Plains Oncology Consortium
Phase 1/2 Terminated
NCT00017134 2013-06-10
Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
GOG Foundation
Phase NA Terminated